Please login to the form below

Not currently logged in
Email:
Password:

CoolSculpting

This page shows the latest CoolSculpting news and features for those working in and with pharma, biotech and healthcare.

AbbVie creates new aesthetics division amid Allergan takeover

AbbVie creates new aesthetics division amid Allergan takeover

The aesthetic products included in this separate division will be cosmetic Botox, the Juvaderm collection of dermal fillers and Coolsculpting body contouring, among others.

Latest news

  • Allergan adds Zeltiq to M&A roster in $2.48n deal Allergan adds Zeltiq to M&A roster in $2.48n deal

    Zeltiq's CoolSculpting system is approved by the FDA and addresses a growing market currently valued at around $4bn a year worldwide, said Allergan, which maintains the product is the sales ... With CoolSculpting, our offerings to plastic surgeons,

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    ZELTIQ's technology, the CoolSculpting System, is the market leader in the rapidly growing body contouring segment of medical aesthetics, which is currently worth around $4bn worldwide. ... Royalty monetisation. 2, 850. ZELTIQ Aesthetics/ Allergan.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics